Earnings Feed
Start Free
$REGN·4

REGENERON PHARMACEUTICALS INC · Jun 19, 4:44 PM ET

REGENERON PHARMACEUTICALS INC 4

4 · REGENERON PHARMACEUTICALS INC · Filed Jun 19, 2017

Insider Transaction Report

Form 4
Period: 2017-06-15
REGENERON PHARMACEUTICALS INCREGN
Terifay Robert J
SVP Commercial
Transactions
  • Exercise/Conversion

    Common Stock

    2017-06-15$52.03/sh+48,750$2,536,463→ 72,043 total
  • Sale

    Common Stock

    2017-06-16$468.19/sh−21,147$9,900,814→ 23,293 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2017-06-15−48,750→ 30,579 total
    Exercise: $52.03Exp: 2021-12-16→ Common Stock (48,750 underlying)
  • Tax Payment

    Common Stock

    2017-06-15$468.69/sh−22,192$10,401,168→ 44,440 total
  • Tax Payment

    Common Stock

    2017-06-15$468.69/sh−5,411$2,536,082→ 66,632 total
Holdings

  • Common Stock

    (indirect: By 401(k))
    1,699
Footnotes (2)
  • [F1]Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  • [F2]The option became exercisable with respect to all shares underlying the option on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT